The Natural History of Residual and Recurrent Disease in Advanced Juvenile Nasopharyngeal Angiofibroma: A Systematic Review.

LaryngoscopeMay 24, 2026 (epub)
Clinical ResearchOtolaryngology (ENT)

Shivani Angelique Kumar, Peter Petocz, Raewyn G Campbell

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined the natural history of residual and recurrent juvenile nasopharyngeal angiofibromas (JNAs) in 131 male patients, average age 16.3 years. The study found that 41% of cases showed complete involution, while only 2% exhibited progressive disease. A significant association was noted between treatment modality and outcomes (p = 0.015), particularly favoring radiotherapy.

Key findings

  • 41% of patients experienced complete involution of residual or recurrent JNAs.
  • Only 2% of patients had progressive disease.
  • Radiotherapy showed the highest rates of spontaneous involution among treatment modalities.
  • 29% of cases remained stable, and 25% showed a reduction in size.

Why it matters

Understanding the natural history of residual and recurrent JNAs can guide clinicians in making informed decisions about treatment and surveillance, particularly in young patients where intervention risks must be carefully weighed.

Source

Published in Laryngoscope. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Otolaryngology (ENT)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.